Related Experiment Video

Updated: Jul 16, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
09:06

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method

Published on: October 7, 2025

Genetic unmasking of an epigenetically silenced microRNA in human cancer cells

Amaia Lujambio1, Santiago Ropero, Esteban Ballestar

  • 1Cancer Epigenetics Laboratory and Lung Cancer Laboratory, Spanish National Cancer Centre (CNIO), Melchor Fernandez Almagro 3, 28029 Madrid, Spain.

Cancer Research
|February 20, 2007
PubMed

Insights

Epigenetic changes like DNA hypomethylation can release microRNA (miRNA) silencing in cancer cells. This study shows DNA hypomethylation reactivates tumor-suppressing miRNAs, such as miRNA-124a, impacting cancer development.

Area of Science:

  • Molecular Biology
  • Epigenetics
  • Oncology

Background:

  • MicroRNA (miRNA) disruption mechanisms in human diseases remain unclear.
  • CpG island promoter hypermethylation commonly silences tumor suppressor genes in cancer.
  • The potential for epigenetic silencing of miRNAs in cancer cells is unexplored.

Purpose of the Study:

  • To investigate whether epigenetic modifications, specifically DNA methylation, affect miRNA expression in cancer cells.
  • To determine if DNA hypomethylation can reverse miRNA silencing in transformed cells.
  • To identify specific miRNAs targeted by epigenetic silencing in human tumors.

Main Methods:

  • Utilized cancer cell lines genetically deficient in DNA methyltransferase enzymes.
  • Employed miRNA expression profiling to analyze miRNA alterations.
  • Investigated the epigenetic regulation of miRNA-124a in various human tumors.

Main Results:

  • DNA hypomethylation was observed to release miRNA silencing in cancer cells.
  • miRNA-124a was identified as a key target, transcriptionally inactivated by CpG island hypermethylation in human tumors.
  • Epigenetic loss of miRNA-124a was functionally linked to cyclin D kinase 6 activation and retinoblastoma gene phosphorylation.

Conclusions:

  • Epigenetic mechanisms, particularly DNA methylation, play a significant role in miRNA dysregulation in cancer.
  • Reactivation of tumor-suppressive miRNAs like miRNA-124a through DNA hypomethylation has therapeutic implications.
  • The interplay between miRNA epigenetic silencing and oncogenic pathways highlights novel cancer vulnerabilities.

More Related Videos

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis10:40

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis

Published on: April 25, 2022

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library08:40

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...